Variable bioavailability following repeated oral doses of etoposide

References

Page 1

	Year	Citations
The use of the nitrogen mustards in the palliative treatment of carcinoma.With particular reference to bronchogenic carcinoma David A. Karnofsky, Walter H. Abelmann, Lloyd F. Craver, Cancer Palliative TreatmentMedicineNitrogen MustardsPathologyBronchial Neoplasm	1948	2.2K
Drug Treatment. Principles and Practice of Clinical Pharmacology and Therapeutics. Annals of Internal Medicine Pharmacological StudyPharmacodynamicsClinical TherapeuticPharmacologyPharmacological Agent	1980	226
VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules. Franco Cavalli, Roland Sonntag, F Jungi, PubMed MedicineCancer ManagementClinical TrialsDosage SchedulesRandomized Trial	1978	164
SCHEDULE DEPENDENCY OF THE ANTILEUKEMIC ACTIVITY OF THE PODOPHYLLOTOXIN‐DERIVATIVE VP 16–213 (NSC‐141540) IN L1210 LEUKEMIA P Dombernowsky, Nis I. Nissen Acta Pathologica Microbiologica Scandinavica Section A Pathology Hematological MalignancyMolecular PharmacologyMedicinal ChemistryTumor BiologyDivided Treatment	1973	149
Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies. Radice Pa, Bunn Pa, DC Ihde PubMed Other MalignanciesMedicineActive AgentsMetronomic TherapyImmunology	1979	144
Pharmacokinetics of VP16-213 given by different administration methods Maurizio D’Incalci, P. Farina, Cristiana Sessa, Cancer Chemotherapy and Pharmacology PharmacologyDifferent Administration MethodsPharmacotherapyMedicinePharmacokinetics	1982	120
STRIPE: An interactive computer program for the analysis of drug pharmacokinetics A. E. Johnston, R. Woollard Journal of Pharmacological Methods Therapeutic Drug MonitoringDrug AnalysisDrug ResistanceMedicineBioanalysis	1983	112
Comparison of the human pharmacokinetics of VM-26 and VP-16, two antineoplastic epipodophyllotoxin glucopyranoside derivatives Larry M. Allen, Patrick J. Creaven European Journal of Cancer (1965) Pharmaceutical ScienceHuman PharmacokineticsMedicinePharmacotherapyDrug Development	1975	109
Small cell carcinoma of the lung Robert L. Comis Cancer Treatment Reviews MedicineMultiple Pulmonary NoduleHistopathologySmall Cell CarcinomaPathology	1982	70
EPEG, a new antineoplastic epipodophyllotoxin Patrick J. Creaven, Larry M. Allen Clinical Pharmacology & Therapeutics Pharmaceutical SciencePathologyPharmacotherapyNephrologyTumor Biology	1975	64

Page 1